Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective CYP2C9 And VKORC1 Genotyping For Total Hip or Knee Replacement Patients Receiving Warfarin (Coumadin)For Anticoagulation

NCT00634907 is registered in ClinicalTrials.gov with Gwen McMillin as lead sponsor.

NCT NCT00634907
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00634907 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective CYP2C9 And VKORC1 Genotyping For Total Hip or Knee Replacement Patients Receiving Warfarin (Coumadin)For Anticoagulation
Lead sponsor
Gwen McMillin
Phase
Not applicable
Overall status
Completed
Start date
September 30, 2006
Completion date
October 31, 2008
Enrollment
263 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bleeding, venous thromboembolism